<?xml version="1.0" encoding="UTF-8"?>
<p>Since the discovery of EBOV in 1976 in the Democratic Republic of Congo (DRC), BDBV, SUDV, and EBOV have caused sporadic epidemics of lethal hemorrhagic fever or Ebola virus disease (EVD), largely in Central Africa, with case fatality rates of 23–90% [
 <xref rid="pntd.0006530.ref004" ref-type="bibr">4</xref>–
 <xref rid="pntd.0006530.ref007" ref-type="bibr">7</xref>]. In December 2013, an outbreak of EBOV was detected in Guinea, which led to the largest ever recorded epidemic spanning seven West African countries. By 2016, more than 28,000 symptomatic cases of EVD were reported with a case fatality rate of 40% [
 <xref rid="pntd.0006530.ref008" ref-type="bibr">8</xref>]. Although there are several in the pipeline, there are currently no licensed vaccines against EBOV and treatment remains largely supportive.
</p>
